Zhejiang Candorly Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is TENOFOVIR DISOPROXIL FUMARATE, with a corresponding US DMF Number 28460.
Remarkably, this DMF maintains an Active status since its submission on July 21, 2014, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 05, 2015, and payment made on July 15, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II